Chemotherapy of advanced cancer of the colon and rectum
- PMID: 1925632
Chemotherapy of advanced cancer of the colon and rectum
Similar articles
-
[Chemotherapy of metastasizing cancers of the colon and rectum].Ann Chir. 1993;47(6):480-3. Ann Chir. 1993. PMID: 7692804 Review. French. No abstract available.
-
Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity.Cancer Invest. 1990;8(2):263-4. doi: 10.3109/07357909009017578. Cancer Invest. 1990. PMID: 2400946 No abstract available.
-
How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.Med Oncol. 1995 Sep;12(3):187-201. doi: 10.1007/BF01571196. Med Oncol. 1995. PMID: 8852401 Review. No abstract available.
-
Clinical trial of PALA and L-Alanosine in advanced colorectal carcinoma.Cancer Treat Rep. 1983 Dec;67(12):1141-2. Cancer Treat Rep. 1983. PMID: 6360350 Clinical Trial. No abstract available.
-
Clinical trials referral resource. Treatment of advanced colorectal cancer.Oncology (Williston Park). 1991 Apr;5(4):61-2, 65-6, 68 passim. Oncology (Williston Park). 1991. PMID: 1831041 No abstract available.
Cited by
-
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives.Visc Med. 2016 Jun;32(3):178-83. doi: 10.1159/000446052. Epub 2016 Jun 7. Visc Med. 2016. PMID: 27493945 Free PMC article. Review.
-
Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.Curr Med Sci. 2022 Jun;42(3):538-547. doi: 10.1007/s11596-022-2597-1. Epub 2022 Jun 8. Curr Med Sci. 2022. PMID: 35678912
-
Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7.Gut Microbes. 2020 May 3;11(3):511-525. doi: 10.1080/19490976.2019.1695494. Epub 2020 Jan 7. Gut Microbes. 2020. PMID: 31910722 Free PMC article.
-
A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal cancer.Cancer Chemother Pharmacol. 1995;37(1-2):86-90. doi: 10.1007/BF00685633. Cancer Chemother Pharmacol. 1995. PMID: 7497602 Clinical Trial.
-
Bioavailability and feasibility of subcutaneous 5-fluorouracil.Br J Cancer. 1993 Sep;68(3):537-9. doi: 10.1038/bjc.1993.382. Br J Cancer. 1993. PMID: 8353044 Free PMC article.